Search research articles
Contact Us
Filters
Showing results (421-430 of 596) with videos related to
Page
of 60
Sort By:
Stroke
|
April 26, 2014
Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial
Ka Sing Lawrence Wong, Dai Yi Hu, Abraham Oomman, et al.
JACC. Cardiovascular Interventions
|
May 16, 2023
Anonymous Comparison of Various Angiography-Derived Fractional Flow Reserve Software With Pressure-Derived Physiological Assessment
Kai Ninomiya, Patrick W Serruys, Nozomi Kotoku, et al.
European Heart Journal
|
April 11, 2023
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
Alexander P Benz, Stefan H Hohnloser, John W Eikelboom, et al.
Circulation. Cardiovascular Interventions
|
July 13, 2021
Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial
William R Hiatt, Connie N Hess, Marc P Bonaca, et al.
Journal of the American College of Cardiology
|
November 28, 2015
Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial
Matthew W Sherwood, Christopher C Nessel, Anne S Hellkamp, et al.
JAMA Cardiology
|
January 12, 2018
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial
Maros Ferencik, Thomas Mayrhofer, Daniel O Bittner, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 4, 2020
Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial
Chandler A Long, Hillary Mulder, F Gerry R Fowkes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
April 28, 2021
SCAI expert consensus update on best practices in the cardiac catheterization laboratory: This statement was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) in April 2021
Srihari S Naidu, J Dawn Abbott, Jayant Bagai, et al.
Journal of the American College of Cardiology
|
February 11, 2012
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008
J Matthew Brennan, David Dai, Manesh R Patel, et al.
Circulation
|
May 6, 2024
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD
Justin T Morrison, Mario Enrico Canonico, Sonia S Anand, et al.
Page
of 60
Search research articles
Search
Showing results (421-430 of 596) with videos related to
Sort By:
Page
of 60
Stroke
|
April 26, 2014
Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial
Ka Sing Lawrence Wong, Dai Yi Hu, Abraham Oomman, et al.
JACC. Cardiovascular Interventions
|
May 16, 2023
Anonymous Comparison of Various Angiography-Derived Fractional Flow Reserve Software With Pressure-Derived Physiological Assessment
Kai Ninomiya, Patrick W Serruys, Nozomi Kotoku, et al.
European Heart Journal
|
April 11, 2023
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
Alexander P Benz, Stefan H Hohnloser, John W Eikelboom, et al.
Circulation. Cardiovascular Interventions
|
July 13, 2021
Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial
William R Hiatt, Connie N Hess, Marc P Bonaca, et al.
Journal of the American College of Cardiology
|
November 28, 2015
Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial
Matthew W Sherwood, Christopher C Nessel, Anne S Hellkamp, et al.
JAMA Cardiology
|
January 12, 2018
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial
Maros Ferencik, Thomas Mayrhofer, Daniel O Bittner, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 4, 2020
Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial
Chandler A Long, Hillary Mulder, F Gerry R Fowkes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
April 28, 2021
SCAI expert consensus update on best practices in the cardiac catheterization laboratory: This statement was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) in April 2021
Srihari S Naidu, J Dawn Abbott, Jayant Bagai, et al.
Journal of the American College of Cardiology
|
February 11, 2012
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008
J Matthew Brennan, David Dai, Manesh R Patel, et al.
Circulation
|
May 6, 2024
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD
Justin T Morrison, Mario Enrico Canonico, Sonia S Anand, et al.
Page
of 60